Skip to main content

Table 2 Demographic data

From: Exploring the assessment of post-cardiac valve surgery pulmonary complication risks through the integration of wearable continuous physiological and clinical data

Variable

PPCs

(N = 22)

Non-PPCs

(N = 78)

Total

(N = 100)

Demographics

 Gender (male), n (%)

13 (59.0)

55 (70.5)

68 (68)

 Age (years), mean ± SD

57.77 ± 10.54

66.21 ± 11.62

64.35 ± 11.87

 Height (cm), mean ± SD

160.95 ± 8.45

160.59 ± 8.15

145.67 ± 8.18

 Weight (kg), mean ± SD

62.75 ± 15.53

60.59 ± 10.08

61.07 ± 11.45

 BMI, mean ± SD

24.11 ± 4.97

23.48 ± 3.35

23.62 ± 3.75

Principal Diagnosis, n (%)

 NYHA classification

   

  II

11 (50.0)

40 (51.3)

51 (51)

  III

10 (45.5)

36 (46.2)

46 (46)

  IV

1 (4.5)

2 (2.5)

3 (3)

 EuroSCORE II, mean ± SD

4.36 ± 3.32

5.14 ± 2.80

4.97 ± 2.92

 Hypertension

8 (36.3)

39 (50)

47 (47)

 Preoperative smoking history

6 (27.2)

20 (25.6)

26 (26)

 Preoperative anemia

1 (4.5)

3 (3.8)

4 (4)

 Respiratory infection in the past month

1(4.5)

2 (2.5)

3 (3)

 Congestive heart failure

16 (72.7)

64 (82.1)

80 (80)

 Preoperative hypoxemia

6 (27.2)

28 (35.9)

34 (34)

 Previous thoracotomy

2 (9.0)

5 (6.4)

7 (7)

Surgical method, n (%)

 TAVR

3 (13.6)

51 (65.3)

54 (54)

 SAVR

19 (86.3)

27 (34.6)

46 (46)

  1. Notes: Demographic data is given as ‘mean ± standard deviation’ or ‘N (%)’, as appropriate. PPCs, postoperative pulmonary complications; SD, standard deviation; BMI, body mass index; NYHA, New York Heart Association; EuroSCORE II, the European System for Cardiac Operative Risk Evaluation II; TAVR, transcatheter aortic valve replacement; SAVR, surgical aortic valve replacement